NASDAQ:CLRB | Cash Flow Statement | Cellectar Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2003-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$6.93M
2026-03-31-$5.65M-$4.85M$3,378.00-$3,378.00
2025-12-31-$5.3M$49,461.00-$4.34M$4.99M
2025-09-30-$4.44M
2025-06-30-$5.45M
2025-03-31-$6.6M$56,295.00-$9.38M
2024-12-31-$2.36M$68,571.00-$10.91M$61,286.00-$61,286.00$0.00
2024-09-30-$14.66M
2024-06-30-$919,371.00
2024-03-31-$26.64M$88,490.00-$13.36M$21,633.00-$21,633.00$43.85M
2023-12-31-$7.88M$69,960.00-$9.6M$266,756.00-$266,756.00$441,001.00
2023-09-30-$17.52M
2023-06-30-$10.18M
2023-03-31-$7.19M$42,557.00-$7.18M$3.00
2022-12-31-$7.22M$38,159.00-$7.41M$117,856.00-$117,856.00
2022-09-30-$7.81M
2022-06-30-$7.44M
2022-03-31-$6.14M$43,417.00-$5.04M$30,070.00-$30,070.00
2021-12-31-$5.92M$39,291.00-$4.51M$129,739.00-$129,739.00-$1.00
2021-09-30-$5.82M
2021-06-30-$6.03M
2021-03-31-$6.36M$35,130.00-$4.75M$1.21M
2020-12-31-$3.62M$35,924.00-$3.87M$17,210.00-$17,210.00$42.21M
2020-09-30-$3.91M
2020-06-30-$3.61M
2020-03-31-$3.96M$33,936.00-$3.51M$10,553.00-$10,553.00$0.00
2019-12-31-$3.38M$32,582.00-$2.68M$5,725.00-$5,725.00$0.00
2019-09-30-$3.9M
2019-06-30-$3.19M
2019-03-31-$3.62M$32,733.00-$2.82M$6,242.00-$6,242.00-$811.00
2018-12-31-$3.83M$32,214.00-$2.74M$383,568.00-$373,568.00-$790.00
2018-09-30-$3.01M
2018-06-30-$2.92M
2018-03-31-$3.48M$17,301.00-$3.18M$1,425.00-$1,425.00-$728.00
2017-12-31-$4.08M$1.25M-$2.83M$0.00$0.00$7.17M
2017-09-30-$3.47M
2017-06-30-$3.12M
2017-03-31-$2.89M$86,911.00-$2.99M$66,301.00-$66,301.00$2.85M
2016-12-31-$2.59M$87,348.00-$2.35M$66,993.00-$66,993.00$8.21M
2016-09-30-$2.29M
2016-06-30-$2.13M
2016-03-31$824,563.00$90,773.00-$1.82M$0.00
2015-12-31$950,913.00$90,994.00-$1.49M$18,683.00
2015-09-30-$1.86M
2015-06-30-$2.29M
2015-03-31-$2.3M$90,044.00-$2.37M$25,466.00
2014-12-31-$3.35M$89,509.00-$2.14M$12,172.00
2014-09-30$324,022.00
2014-06-30-$2.09M
2014-03-31-$2.94M$96,048.00-$2.59M$15,191.00$0.00
2013-12-31-$3.95M$99,098.00-$2.68M$12,856.00$0.00
2013-09-30-$1.32M
2013-06-30-$2.06M
2013-03-31-$3.45M$111,874.00-$1.89M$92,977.00$28,763.00$0.00$5.05M
2012-12-31-$2.16M$113,170.00-$1.69M$60,549.00-$2.06M$0.00$2.83M
2012-09-30-$2.05M
2012-06-30-$2.23M
2012-03-31-$2.36M$139,771.00-$1.7M$15,149.00-$15,149.00$0.00-$544.00
2011-12-31-$1.97M$145,254.00-$1.54M$6,216.00-$6,216.00$0.00$5.46M
2011-09-30-$1.91M
2011-06-30-$2.6M
2011-03-31-$965,252.00$144,174.00-$324,566.00-$50,506.00
2010-12-31-$461,840.00$144,197.00-$113,083.00$400,507.00
2010-09-30-$700,216.00
2010-06-30-$1.62M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$21.79M$213,597.00-$23.12M$5,880.00-$5,880.00$13.03M
2024-12-31-$44.58M$291,653.00-$47.58M$104,195.00-$104,195.00$61.41M
2023-12-31-$42.77M$192,375.00-$32.38M$864,038.00-$864,038.00$22.94M
2022-12-31-$28.6M$148,435.00-$25.22M$225,971.00-$225,971.00$9.61M
2021-12-31-$24.12M$149,915.00-$22.57M$141,361.00-$141,361.00$1.25M
2020-12-31-$15.09M$141,453.00-$13.93M$62,353.00-$62,353.00$60.55M
2019-12-31-$14.09M$132,798.00-$11.69M$24,542.00-$24,542.00$9.02M
2018-12-31-$13.24M$82,265.00-$11.44M$384,993.00-$329,993.00$15.02M
2017-12-31-$13.56M$1.55M-$11.02M$346,703.00-$346,703.00$9.93M
2016-12-31-$6.18M$356,665.00-$8.28M$72,251.00-$72,251.00$15.94M
2015-12-31-$5.5M$362,502.00-$8.21M$58,470.00
2014-12-31-$8.05M$367,197.00-$8.84M$29,569.00
2013-12-31-$10.78M$424,758.00-$9.15M$147,812.00$0.00
2012-12-31-$8.8M$497,253.00-$6.59M$97,691.00-$2.1M$0.00$7.85M
2011-12-31-$7.44M$584,841.00-$5.97M$118,411.00$1.29M$0.00$9.52M
2010-12-31-$4.56M$580,114.00-$3.38M$1,652.00-$1,652.00$3.08M
2009-12-31-$6.22M
2008-12-31-$6.09M
2007-12-31-$5.09M
2006-12-31-$963,440.00
2005-12-31-$481,837.00
2004-12-31-$342,761.00
2003-12-31-$295,790.00